Associations of Resistin Levels with Resistin Gene Polymorphism and Metabolic Syndrome in Thais

Overview

Journal J Med Biochem

Specialty Biochemistry

Date 2017 Mar 31

PMID 28356829

Citations 9

Authors

Kanjana Suriyaprom

Rungsunn Tungtrongchitr

Pisit Namjuntra

Affiliations

Soon will be listed here.

Abstract

Background: Metabolic syndrome (MS) is a clinical constellation comprising risk factors associated with developing cardiovascular disease and type 2 diabetes. Resistin has been suggested as a linkage between obesity, inflammation and type 2 diabetes. This study aimed to investigate resistin concentrations and hematological-biochemical parameters in MS subjects and controls, and to determine whether two resistin gene ( polymorphisms (-420C>G & +299G>A) are linked to resistin levels and MS among Thais.

Methods: This case-control study was performed with 322 Thai volunteers: 160 MS subjects and 162 controls. Anthropometric parameters and hematological-biochemical variables were determined. The -420C>G (rs1862513) and +299G>A (rs3745367) polymorphisms were genotyped by PCR-RFLP technique.

Results: The resistin levels of the MS group were significantly higher than those of the control group. Resistin levels were positively correlated with anthropometric parameters and WBC count in the MS group. According to -420C>G polymorphism, MS subjects with the G allele (CG/GG) (3.9 μg/L) had significantly higher resistin concentrations than in subjects with the CC genotype (2.4 μg/L); with regard to +299G>A polymorphism, carriers with the A allele (GA/AA) (3.8 μg/L) had significantly higher resistin levels than subjects with the GG genotype (2.7 μg/L), after adjusting for potential covariates. However, the -420C>G and +299G>A polymorphisms were not found to be associated with MS, hematological-biochemical parameters and anthropometric variables.

Conclusions: These findings suggest resistin levels are linked with MS and the -420C>G and +299G>A polymorphisms have impacted the circulating resistin concentrations. However, these two polymorphisms probably do not influence susceptibility to MS among Thais.

Citing Articles

The rs1862513 promoter variant of resistin gene influences susceptibility to nonalcoholic fatty liver disease.

Nouri S, Navari M, Shafiee R, Mahmoudi T, Rezamand G, Asadi A Rev Assoc Med Bras (1992). 2024; 70(7):e20231537.

PMID: 39045929 PMC: 11262324. DOI: 10.1590/1806-9282.20231537.

Genetic Markers of Insulin Resistance and Atherosclerosis in Type 2 Diabetes Mellitus Patients with Coronary Artery Disease.

Perumalsamy S, Huri H, Abdullah B, Mazlan O, Wan Ahmad W, Vethakkan S Metabolites. 2023; 13(3).

PMID: 36984867 PMC: 10054456. DOI: 10.3390/metabo13030427.

The Effects of Resistin Gene Polymorphism on Pain Thresholds and Postoperative Sufentanil Consumption in Gastric Cancer Patients.

Li J, Li S, Yu L, Wei J, Li S, Tan H J Pain Res. 2022; 15:1995-2004.

PMID: 35873952 PMC: 9304898. DOI: 10.2147/JPR.S372845.

Variation of Gene Is Correlated with Insulin Resistance in Obese People of Indonesia.

Hastuti P, Tasmini T, Utami R, Riwa M, Steven S, Sadewa A Open Access Maced J Med Sci. 2019; 7(12):1891-1895.

PMID: 31406524 PMC: 6684434. DOI: 10.3889/oamjms.2019.456.

Relevance of single-nucleotide polymorphism to the expression of resistin gene affecting serum and gingival crevicular fluid resistin levels in chronic periodontitis and type 2 diabetes mellitus: A randomized control clinical trial.

Rode P, Kolte R, Kolte A, Purohit H, Ahuja C J Indian Soc Periodontol. 2019; 23(2):131-136.

PMID: 30983784 PMC: 6434728. DOI: 10.4103/jisp.jisp_361_18.

References

Guilherme A, Virbasius J, Puri V, Czech M . Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol. 2008; 9(5):367-77. PMC: 2886982. DOI: 10.1038/nrm2391. View

Lau C, Muniandy S . Influence of adiponectin and resistin gene polymorphisms on quantitative traits related to metabolic syndrome among Malay, Chinese, and Indian men in Malaysia. Biochem Genet. 2012; 51(1-2):166-74. DOI: 10.1007/s10528-012-9552-y. View

Tsukada S, Tanaka Y, Maegawa H, Kashiwagi A, Kawamori R, Maeda S . Intronic polymorphisms within TFAP2B regulate transcriptional activity and affect adipocytokine gene expression in differentiated adipocytes. Mol Endocrinol. 2005; 20(5):1104-11. DOI: 10.1210/me.2005-0311. View

McTernan C, McTernan P, Harte A, Levick P, Barnett A, Kumar S . Resistin, central obesity, and type 2 diabetes. Lancet. 2002; 359(9300):46-7. DOI: 10.1016/s0140-6736(02)07281-1. View

Rajala M, Scherer P . Minireview: The adipocyte--at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology. 2003; 144(9):3765-73. DOI: 10.1210/en.2003-0580. View

Ukkola O, Kunnari A, Kesaniemi Y . Genetic variants at the resistin locus are associated with the plasma resistin concentration and cardiovascular risk factors. Regul Pept. 2008; 149(1-3):56-9. DOI: 10.1016/j.regpep.2007.08.025. View

Aekplakorn W, Kessomboon P, Sangthong R, Chariyalertsak S, Putwatana P, Inthawong R . Urban and rural variation in clustering of metabolic syndrome components in the Thai population: results from the fourth National Health Examination Survey 2009. BMC Public Health. 2011; 11:854. PMC: 3282716. DOI: 10.1186/1471-2458-11-854. View

Qasim A, Metkus T, Tadesse M, Lehrke M, Restine S, Wolfe M . Resistin gene variation is associated with systemic inflammation but not plasma adipokine levels, metabolic syndrome or coronary atherosclerosis in nondiabetic Caucasians. Clin Endocrinol (Oxf). 2008; 70(5):698-705. PMC: 3108432. DOI: 10.1111/j.1365-2265.2008.03375.x. View

Miyamoto Y, Morisaki H, Kokubo Y, Yamanaka I, Tomoike H, Okayama A . Resistin gene variations are associated with the metabolic syndrome in Japanese men. Obes Res Clin Pract. 2013; 3(2):I-II. DOI: 10.1016/j.orcp.2008.11.003. View

10.

Mojiminiyi O, Abdella N . Associations of resistin with inflammation and insulin resistance in patients with type 2 diabetes mellitus. Scand J Clin Lab Invest. 2007; 67(2):215-25. DOI: 10.1080/00365510601032532. View

11.

Menzaghi C, Coco A, Salvemini L, Thompson R, De Cosmo S, Doria A . Heritability of serum resistin and its genetic correlation with insulin resistance-related features in nondiabetic Caucasians. J Clin Endocrinol Metab. 2006; 91(7):2792-5. DOI: 10.1210/jc.2005-2715. View

12.

Osawa H, Yamada K, Onuma H, Murakami A, Ochi M, Kawata H . The G/G genotype of a resistin single-nucleotide polymorphism at -420 increases type 2 diabetes mellitus susceptibility by inducing promoter activity through specific binding of Sp1/3. Am J Hum Genet. 2004; 75(4):678-86. PMC: 1182055. DOI: 10.1086/424761. View

13.

Nagaev I, Bokarewa M, Tarkowski A, Smith U . Human resistin is a systemic immune-derived proinflammatory cytokine targeting both leukocytes and adipocytes. PLoS One. 2006; 1:e31. PMC: 1762367. DOI: 10.1371/journal.pone.0000031. View

14.

Gupta V, Singh A, Gupta V, Kumar S, Srivastava N, Jafar T . Association of circulating resistin with metabolic risk factors in Indian females having metabolic syndrome. Toxicol Int. 2011; 18(2):168-72. PMC: 3183627. DOI: 10.4103/0971-6580.84272. View

15.

Gnacinska M, Malgorzewicz S, Lysiak-Szydlowska W, Sworczak K . The serum profile of adipokines in overweight patients with metabolic syndrome. Endokrynol Pol. 2010; 61(1):36-41. View

16.

Hivert M, Manning A, McAteer J, Dupuis J, Fox C, Cupples L . Association of variants in RETN with plasma resistin levels and diabetes-related traits in the Framingham Offspring Study. Diabetes. 2008; 58(3):750-6. PMC: 2646076. DOI: 10.2337/db08-1339. View

17.

Asano H, Izawa H, Nagata K, Nakatochi M, Kobayashi M, Hirashiki A . Plasma resistin concentration determined by common variants in the resistin gene and associated with metabolic traits in an aged Japanese population. Diabetologia. 2009; 53(2):234-46. DOI: 10.1007/s00125-009-1517-2. View

18.

Musialik K . The influence of chosen adipocytokines on blood pressure values in patients with metabolic syndrome. Kardiol Pol. 2012; 70(12):1237-42. View

19.

Lau C, Muniandy S . Adiponectin and resistin gene polymorphisms in association with their respective adipokine levels. Ann Hum Genet. 2011; 75(3):370-82. DOI: 10.1111/j.1469-1809.2010.00635.x. View

20.

de Luis D, Gonzalez Sagrado M, Conde R, Aller R, Izaola O, Primo D . Lack of association of serum resistin levels with metabolic syndrome criteria in obese female patients. Clin Biochem. 2011; 44(16):1280-3. DOI: 10.1016/j.clinbiochem.2011.09.002. View